nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC22A7—Docetaxel—melanoma	0.169	0.275	CbGbCtD
Zalcitabine—CYP3A4—Temozolomide—melanoma	0.102	0.166	CbGbCtD
Zalcitabine—CYP2D6—Vemurafenib—melanoma	0.088	0.143	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0657	0.107	CbGbCtD
Zalcitabine—CYP3A7—Docetaxel—melanoma	0.0657	0.107	CbGbCtD
Zalcitabine—CYP3A4—Vemurafenib—melanoma	0.056	0.091	CbGbCtD
Zalcitabine—CYP3A5—Docetaxel—melanoma	0.0492	0.0801	CbGbCtD
Zalcitabine—CYP3A4—Docetaxel—melanoma	0.0192	0.0312	CbGbCtD
Zalcitabine—Neutropenia—Temozolomide—melanoma	0.000695	0.00208	CcSEcCtD
Zalcitabine—Hyperglycaemia—Carmustine—melanoma	0.000694	0.00207	CcSEcCtD
Zalcitabine—Pollakiuria—Temozolomide—melanoma	0.000687	0.00205	CcSEcCtD
Zalcitabine—Depression—Carmustine—melanoma	0.000684	0.00204	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Temozolomide—melanoma	0.000679	0.00203	CcSEcCtD
Zalcitabine—Weight decreased—Temozolomide—melanoma	0.000673	0.00201	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Carmustine—melanoma	0.000672	0.00201	CcSEcCtD
Zalcitabine—Hyperglycaemia—Temozolomide—melanoma	0.000671	0.002	CcSEcCtD
Zalcitabine—Depression—Temozolomide—melanoma	0.000661	0.00198	CcSEcCtD
Zalcitabine—Hepatitis—Dactinomycin—melanoma	0.000658	0.00197	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000658	0.00197	CcSEcCtD
Zalcitabine—Flushing—Bleomycin—melanoma	0.000655	0.00196	CcSEcCtD
Zalcitabine—Body temperature increased—Vemurafenib—melanoma	0.000654	0.00195	CcSEcCtD
Zalcitabine—Pharyngitis—Dactinomycin—melanoma	0.000653	0.00195	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Temozolomide—melanoma	0.00065	0.00194	CcSEcCtD
Zalcitabine—Swelling—Docetaxel—melanoma	0.000649	0.00194	CcSEcCtD
Zalcitabine—Deafness—Docetaxel—melanoma	0.00064	0.00191	CcSEcCtD
Zalcitabine—Chills—Bleomycin—melanoma	0.000633	0.00189	CcSEcCtD
Zalcitabine—Alopecia—Bleomycin—melanoma	0.000623	0.00186	CcSEcCtD
Zalcitabine—Sinusitis—Temozolomide—melanoma	0.000622	0.00186	CcSEcCtD
Zalcitabine—Hallucination—Carmustine—melanoma	0.000613	0.00183	CcSEcCtD
Zalcitabine—Hot flush—Docetaxel—melanoma	0.000612	0.00183	CcSEcCtD
Zalcitabine—Flushing—Dactinomycin—melanoma	0.000611	0.00182	CcSEcCtD
Zalcitabine—Hypersensitivity—Vemurafenib—melanoma	0.00061	0.00182	CcSEcCtD
Zalcitabine—Menopausal symptoms—Docetaxel—melanoma	0.000606	0.00181	CcSEcCtD
Zalcitabine—Atrial fibrillation—Docetaxel—melanoma	0.000604	0.0018	CcSEcCtD
Zalcitabine—Renal impairment—Docetaxel—melanoma	0.000601	0.0018	CcSEcCtD
Zalcitabine—Dermatitis bullous—Docetaxel—melanoma	0.000599	0.00179	CcSEcCtD
Zalcitabine—Hepatitis—Temozolomide—melanoma	0.000595	0.00178	CcSEcCtD
Zalcitabine—Asthenia—Vemurafenib—melanoma	0.000594	0.00177	CcSEcCtD
Zalcitabine—Visual impairment—Carmustine—melanoma	0.000594	0.00177	CcSEcCtD
Zalcitabine—Hallucination—Temozolomide—melanoma	0.000592	0.00177	CcSEcCtD
Zalcitabine—Pharyngitis—Temozolomide—melanoma	0.000591	0.00176	CcSEcCtD
Zalcitabine—Chills—Dactinomycin—melanoma	0.00059	0.00176	CcSEcCtD
Zalcitabine—Cardiac failure—Docetaxel—melanoma	0.000586	0.00175	CcSEcCtD
Zalcitabine—Pruritus—Vemurafenib—melanoma	0.000585	0.00175	CcSEcCtD
Zalcitabine—Alopecia—Dactinomycin—melanoma	0.000581	0.00174	CcSEcCtD
Zalcitabine—Eye disorder—Carmustine—melanoma	0.000576	0.00172	CcSEcCtD
Zalcitabine—Hyponatraemia—Docetaxel—melanoma	0.000574	0.00172	CcSEcCtD
Zalcitabine—Visual impairment—Temozolomide—melanoma	0.000574	0.00171	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000572	0.00171	CcSEcCtD
Zalcitabine—Pain in extremity—Docetaxel—melanoma	0.000572	0.00171	CcSEcCtD
Zalcitabine—Flushing—Carmustine—melanoma	0.000572	0.00171	CcSEcCtD
Zalcitabine—Ill-defined disorder—Bleomycin—melanoma	0.00057	0.0017	CcSEcCtD
Zalcitabine—Anaemia—Bleomycin—melanoma	0.000568	0.0017	CcSEcCtD
Zalcitabine—Diarrhoea—Vemurafenib—melanoma	0.000566	0.00169	CcSEcCtD
Zalcitabine—Migraine—Docetaxel—melanoma	0.000563	0.00168	CcSEcCtD
Zalcitabine—Eye disorder—Temozolomide—melanoma	0.000556	0.00166	CcSEcCtD
Zalcitabine—Tinnitus—Temozolomide—melanoma	0.000555	0.00166	CcSEcCtD
Zalcitabine—Malaise—Bleomycin—melanoma	0.000554	0.00165	CcSEcCtD
Zalcitabine—Flushing—Temozolomide—melanoma	0.000552	0.00165	CcSEcCtD
Zalcitabine—Arrhythmia—Carmustine—melanoma	0.00055	0.00164	CcSEcCtD
Zalcitabine—Leukopenia—Bleomycin—melanoma	0.00055	0.00164	CcSEcCtD
Zalcitabine—Dizziness—Vemurafenib—melanoma	0.000547	0.00163	CcSEcCtD
Zalcitabine—Alopecia—Carmustine—melanoma	0.000544	0.00163	CcSEcCtD
Zalcitabine—Ataxia—Docetaxel—melanoma	0.000538	0.00161	CcSEcCtD
Zalcitabine—Cough—Bleomycin—melanoma	0.000536	0.0016	CcSEcCtD
Zalcitabine—Chills—Temozolomide—melanoma	0.000534	0.0016	CcSEcCtD
Zalcitabine—Ill-defined disorder—Dactinomycin—melanoma	0.000531	0.00159	CcSEcCtD
Zalcitabine—Anaemia—Dactinomycin—melanoma	0.000529	0.00158	CcSEcCtD
Zalcitabine—Vomiting—Vemurafenib—melanoma	0.000526	0.00157	CcSEcCtD
Zalcitabine—Alopecia—Temozolomide—melanoma	0.000526	0.00157	CcSEcCtD
Zalcitabine—Dry skin—Docetaxel—melanoma	0.000524	0.00157	CcSEcCtD
Zalcitabine—Myalgia—Bleomycin—melanoma	0.000523	0.00156	CcSEcCtD
Zalcitabine—Abdominal pain upper—Docetaxel—melanoma	0.000523	0.00156	CcSEcCtD
Zalcitabine—Rash—Vemurafenib—melanoma	0.000522	0.00156	CcSEcCtD
Zalcitabine—Dermatitis—Vemurafenib—melanoma	0.000521	0.00156	CcSEcCtD
Zalcitabine—Back pain—Carmustine—melanoma	0.000519	0.00155	CcSEcCtD
Zalcitabine—Headache—Vemurafenib—melanoma	0.000518	0.00155	CcSEcCtD
Zalcitabine—Discomfort—Bleomycin—melanoma	0.000517	0.00154	CcSEcCtD
Zalcitabine—Malaise—Dactinomycin—melanoma	0.000517	0.00154	CcSEcCtD
Zalcitabine—Cramp muscle—Docetaxel—melanoma	0.000515	0.00154	CcSEcCtD
Zalcitabine—Leukopenia—Dactinomycin—melanoma	0.000513	0.00153	CcSEcCtD
Zalcitabine—Nasopharyngitis—Docetaxel—melanoma	0.000512	0.00153	CcSEcCtD
Zalcitabine—Dysgeusia—Temozolomide—melanoma	0.000507	0.00152	CcSEcCtD
Zalcitabine—Confusional state—Bleomycin—melanoma	0.000505	0.00151	CcSEcCtD
Zalcitabine—Vision blurred—Carmustine—melanoma	0.000505	0.00151	CcSEcCtD
Zalcitabine—Tremor—Carmustine—melanoma	0.000502	0.0015	CcSEcCtD
Zalcitabine—Oedema—Bleomycin—melanoma	0.000501	0.0015	CcSEcCtD
Zalcitabine—Back pain—Temozolomide—melanoma	0.000501	0.0015	CcSEcCtD
Zalcitabine—Infection—Bleomycin—melanoma	0.000498	0.00149	CcSEcCtD
Zalcitabine—Anaemia—Carmustine—melanoma	0.000496	0.00148	CcSEcCtD
Zalcitabine—Dysphagia—Docetaxel—melanoma	0.000494	0.00148	CcSEcCtD
Zalcitabine—Agitation—Carmustine—melanoma	0.000493	0.00147	CcSEcCtD
Zalcitabine—Thrombocytopenia—Bleomycin—melanoma	0.000491	0.00147	CcSEcCtD
Zalcitabine—Vision blurred—Temozolomide—melanoma	0.000488	0.00146	CcSEcCtD
Zalcitabine—Myalgia—Dactinomycin—melanoma	0.000488	0.00146	CcSEcCtD
Zalcitabine—Tremor—Temozolomide—melanoma	0.000485	0.00145	CcSEcCtD
Zalcitabine—Discomfort—Dactinomycin—melanoma	0.000482	0.00144	CcSEcCtD
Zalcitabine—Ill-defined disorder—Temozolomide—melanoma	0.000481	0.00144	CcSEcCtD
Zalcitabine—Leukopenia—Carmustine—melanoma	0.00048	0.00143	CcSEcCtD
Zalcitabine—Anaemia—Temozolomide—melanoma	0.000479	0.00143	CcSEcCtD
Zalcitabine—Anorexia—Bleomycin—melanoma	0.000478	0.00143	CcSEcCtD
Zalcitabine—Agitation—Temozolomide—melanoma	0.000476	0.00142	CcSEcCtD
Zalcitabine—Oedema—Dactinomycin—melanoma	0.000467	0.0014	CcSEcCtD
Zalcitabine—Malaise—Temozolomide—melanoma	0.000467	0.0014	CcSEcCtD
Zalcitabine—Vertigo—Temozolomide—melanoma	0.000465	0.00139	CcSEcCtD
Zalcitabine—Convulsion—Carmustine—melanoma	0.000465	0.00139	CcSEcCtD
Zalcitabine—Infection—Dactinomycin—melanoma	0.000464	0.00139	CcSEcCtD
Zalcitabine—Leukopenia—Temozolomide—melanoma	0.000464	0.00139	CcSEcCtD
Zalcitabine—Hypertension—Carmustine—melanoma	0.000463	0.00138	CcSEcCtD
Zalcitabine—Neutropenia—Docetaxel—melanoma	0.000462	0.00138	CcSEcCtD
Zalcitabine—Palpitations—Temozolomide—melanoma	0.000458	0.00137	CcSEcCtD
Zalcitabine—Thrombocytopenia—Dactinomycin—melanoma	0.000458	0.00137	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000457	0.00136	CcSEcCtD
Zalcitabine—Myalgia—Carmustine—melanoma	0.000456	0.00136	CcSEcCtD
Zalcitabine—Anxiety—Carmustine—melanoma	0.000455	0.00136	CcSEcCtD
Zalcitabine—Cough—Temozolomide—melanoma	0.000452	0.00135	CcSEcCtD
Zalcitabine—Convulsion—Temozolomide—melanoma	0.000449	0.00134	CcSEcCtD
Zalcitabine—Weight decreased—Docetaxel—melanoma	0.000447	0.00134	CcSEcCtD
Zalcitabine—Hypertension—Temozolomide—melanoma	0.000447	0.00134	CcSEcCtD
Zalcitabine—Dyspnoea—Bleomycin—melanoma	0.000447	0.00134	CcSEcCtD
Zalcitabine—Anorexia—Dactinomycin—melanoma	0.000446	0.00133	CcSEcCtD
Zalcitabine—Confusional state—Carmustine—melanoma	0.000441	0.00132	CcSEcCtD
Zalcitabine—Arthralgia—Temozolomide—melanoma	0.000441	0.00132	CcSEcCtD
Zalcitabine—Myalgia—Temozolomide—melanoma	0.000441	0.00132	CcSEcCtD
Zalcitabine—Anxiety—Temozolomide—melanoma	0.00044	0.00131	CcSEcCtD
Zalcitabine—Oedema—Carmustine—melanoma	0.000438	0.00131	CcSEcCtD
Zalcitabine—Discomfort—Temozolomide—melanoma	0.000436	0.0013	CcSEcCtD
Zalcitabine—Decreased appetite—Bleomycin—melanoma	0.000436	0.0013	CcSEcCtD
Zalcitabine—Infection—Carmustine—melanoma	0.000435	0.0013	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Docetaxel—melanoma	0.000432	0.00129	CcSEcCtD
Zalcitabine—Dry mouth—Temozolomide—melanoma	0.000431	0.00129	CcSEcCtD
Zalcitabine—Jaundice—Docetaxel—melanoma	0.00043	0.00128	CcSEcCtD
Zalcitabine—Pain—Bleomycin—melanoma	0.000429	0.00128	CcSEcCtD
Zalcitabine—Thrombocytopenia—Carmustine—melanoma	0.000428	0.00128	CcSEcCtD
Zalcitabine—Tachycardia—Carmustine—melanoma	0.000427	0.00128	CcSEcCtD
Zalcitabine—Confusional state—Temozolomide—melanoma	0.000426	0.00127	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000426	0.00127	CcSEcCtD
Zalcitabine—Oedema—Temozolomide—melanoma	0.000423	0.00126	CcSEcCtD
Zalcitabine—Infection—Temozolomide—melanoma	0.00042	0.00126	CcSEcCtD
Zalcitabine—Anorexia—Carmustine—melanoma	0.000417	0.00125	CcSEcCtD
Zalcitabine—Epistaxis—Docetaxel—melanoma	0.000416	0.00124	CcSEcCtD
Zalcitabine—Thrombocytopenia—Temozolomide—melanoma	0.000414	0.00124	CcSEcCtD
Zalcitabine—Feeling abnormal—Bleomycin—melanoma	0.000413	0.00123	CcSEcCtD
Zalcitabine—Skin disorder—Temozolomide—melanoma	0.000411	0.00123	CcSEcCtD
Zalcitabine—Hyperhidrosis—Temozolomide—melanoma	0.000409	0.00122	CcSEcCtD
Zalcitabine—Decreased appetite—Dactinomycin—melanoma	0.000406	0.00121	CcSEcCtD
Zalcitabine—Fatigue—Dactinomycin—melanoma	0.000403	0.0012	CcSEcCtD
Zalcitabine—Anorexia—Temozolomide—melanoma	0.000403	0.0012	CcSEcCtD
Zalcitabine—Pain—Dactinomycin—melanoma	0.0004	0.00119	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Carmustine—melanoma	0.000399	0.00119	CcSEcCtD
Zalcitabine—Urticaria—Bleomycin—melanoma	0.000398	0.00119	CcSEcCtD
Zalcitabine—Rhinitis—Docetaxel—melanoma	0.000397	0.00119	CcSEcCtD
Zalcitabine—Body temperature increased—Bleomycin—melanoma	0.000396	0.00118	CcSEcCtD
Zalcitabine—Hepatitis—Docetaxel—melanoma	0.000396	0.00118	CcSEcCtD
Zalcitabine—Insomnia—Carmustine—melanoma	0.000396	0.00118	CcSEcCtD
Zalcitabine—Pharyngitis—Docetaxel—melanoma	0.000393	0.00117	CcSEcCtD
Zalcitabine—Dyspnoea—Carmustine—melanoma	0.00039	0.00117	CcSEcCtD
Zalcitabine—Somnolence—Carmustine—melanoma	0.000389	0.00116	CcSEcCtD
Zalcitabine—Feeling abnormal—Dactinomycin—melanoma	0.000385	0.00115	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000385	0.00115	CcSEcCtD
Zalcitabine—Insomnia—Temozolomide—melanoma	0.000382	0.00114	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dactinomycin—melanoma	0.000382	0.00114	CcSEcCtD
Zalcitabine—Visual impairment—Docetaxel—melanoma	0.000381	0.00114	CcSEcCtD
Zalcitabine—Decreased appetite—Carmustine—melanoma	0.00038	0.00114	CcSEcCtD
Zalcitabine—Dyspnoea—Temozolomide—melanoma	0.000377	0.00113	CcSEcCtD
Zalcitabine—Somnolence—Temozolomide—melanoma	0.000376	0.00112	CcSEcCtD
Zalcitabine—Pain—Carmustine—melanoma	0.000374	0.00112	CcSEcCtD
Zalcitabine—Dyspepsia—Temozolomide—melanoma	0.000372	0.00111	CcSEcCtD
Zalcitabine—Eye disorder—Docetaxel—melanoma	0.00037	0.00111	CcSEcCtD
Zalcitabine—Body temperature increased—Dactinomycin—melanoma	0.00037	0.0011	CcSEcCtD
Zalcitabine—Abdominal pain—Dactinomycin—melanoma	0.00037	0.0011	CcSEcCtD
Zalcitabine—Hypersensitivity—Bleomycin—melanoma	0.000369	0.0011	CcSEcCtD
Zalcitabine—Decreased appetite—Temozolomide—melanoma	0.000368	0.0011	CcSEcCtD
Zalcitabine—Flushing—Docetaxel—melanoma	0.000367	0.0011	CcSEcCtD
Zalcitabine—Fatigue—Temozolomide—melanoma	0.000365	0.00109	CcSEcCtD
Zalcitabine—Pain—Temozolomide—melanoma	0.000362	0.00108	CcSEcCtD
Zalcitabine—Feeling abnormal—Carmustine—melanoma	0.000361	0.00108	CcSEcCtD
Zalcitabine—Asthenia—Bleomycin—melanoma	0.00036	0.00107	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Carmustine—melanoma	0.000358	0.00107	CcSEcCtD
Zalcitabine—Chills—Docetaxel—melanoma	0.000355	0.00106	CcSEcCtD
Zalcitabine—Pruritus—Bleomycin—melanoma	0.000355	0.00106	CcSEcCtD
Zalcitabine—Arrhythmia—Docetaxel—melanoma	0.000354	0.00106	CcSEcCtD
Zalcitabine—Alopecia—Docetaxel—melanoma	0.00035	0.00105	CcSEcCtD
Zalcitabine—Feeling abnormal—Temozolomide—melanoma	0.000348	0.00104	CcSEcCtD
Zalcitabine—Body temperature increased—Carmustine—melanoma	0.000346	0.00103	CcSEcCtD
Zalcitabine—Abdominal pain—Carmustine—melanoma	0.000346	0.00103	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Temozolomide—melanoma	0.000346	0.00103	CcSEcCtD
Zalcitabine—Hypersensitivity—Dactinomycin—melanoma	0.000344	0.00103	CcSEcCtD
Zalcitabine—Dysgeusia—Docetaxel—melanoma	0.000337	0.00101	CcSEcCtD
Zalcitabine—Urticaria—Temozolomide—melanoma	0.000336	0.001	CcSEcCtD
Zalcitabine—Asthenia—Dactinomycin—melanoma	0.000335	0.001	CcSEcCtD
Zalcitabine—Body temperature increased—Temozolomide—melanoma	0.000334	0.000999	CcSEcCtD
Zalcitabine—Abdominal pain—Temozolomide—melanoma	0.000334	0.000999	CcSEcCtD
Zalcitabine—Back pain—Docetaxel—melanoma	0.000333	0.000996	CcSEcCtD
Zalcitabine—Muscle spasms—Docetaxel—melanoma	0.000331	0.00099	CcSEcCtD
Zalcitabine—Hypersensitivity—Carmustine—melanoma	0.000322	0.000963	CcSEcCtD
Zalcitabine—Diarrhoea—Dactinomycin—melanoma	0.00032	0.000956	CcSEcCtD
Zalcitabine—Vomiting—Bleomycin—melanoma	0.000319	0.000952	CcSEcCtD
Zalcitabine—Anaemia—Docetaxel—melanoma	0.000318	0.000952	CcSEcCtD
Zalcitabine—Rash—Bleomycin—melanoma	0.000316	0.000944	CcSEcCtD
Zalcitabine—Dermatitis—Bleomycin—melanoma	0.000316	0.000943	CcSEcCtD
Zalcitabine—Asthenia—Carmustine—melanoma	0.000314	0.000938	CcSEcCtD
Zalcitabine—Hypersensitivity—Temozolomide—melanoma	0.000312	0.000931	CcSEcCtD
Zalcitabine—Syncope—Docetaxel—melanoma	0.000309	0.000923	CcSEcCtD
Zalcitabine—Leukopenia—Docetaxel—melanoma	0.000308	0.000922	CcSEcCtD
Zalcitabine—Palpitations—Docetaxel—melanoma	0.000304	0.00091	CcSEcCtD
Zalcitabine—Asthenia—Temozolomide—melanoma	0.000303	0.000906	CcSEcCtD
Zalcitabine—Loss of consciousness—Docetaxel—melanoma	0.000303	0.000905	CcSEcCtD
Zalcitabine—Cough—Docetaxel—melanoma	0.000301	0.000898	CcSEcCtD
Zalcitabine—Diarrhoea—Carmustine—melanoma	0.000299	0.000895	CcSEcCtD
Zalcitabine—Pruritus—Temozolomide—melanoma	0.000299	0.000894	CcSEcCtD
Zalcitabine—Convulsion—Docetaxel—melanoma	0.000299	0.000892	CcSEcCtD
Zalcitabine—Hypertension—Docetaxel—melanoma	0.000297	0.000889	CcSEcCtD
Zalcitabine—Vomiting—Dactinomycin—melanoma	0.000297	0.000888	CcSEcCtD
Zalcitabine—Rash—Dactinomycin—melanoma	0.000295	0.000881	CcSEcCtD
Zalcitabine—Arthralgia—Docetaxel—melanoma	0.000293	0.000876	CcSEcCtD
Zalcitabine—Myalgia—Docetaxel—melanoma	0.000293	0.000876	CcSEcCtD
Zalcitabine—Dizziness—Carmustine—melanoma	0.000289	0.000865	CcSEcCtD
Zalcitabine—Diarrhoea—Temozolomide—melanoma	0.000289	0.000864	CcSEcCtD
Zalcitabine—Dry mouth—Docetaxel—melanoma	0.000287	0.000857	CcSEcCtD
Zalcitabine—Confusional state—Docetaxel—melanoma	0.000284	0.000847	CcSEcCtD
Zalcitabine—Oedema—Docetaxel—melanoma	0.000281	0.00084	CcSEcCtD
Zalcitabine—Dizziness—Temozolomide—melanoma	0.00028	0.000835	CcSEcCtD
Zalcitabine—Infection—Docetaxel—melanoma	0.000279	0.000835	CcSEcCtD
Zalcitabine—Vomiting—Carmustine—melanoma	0.000278	0.000831	CcSEcCtD
Zalcitabine—Shock—Docetaxel—melanoma	0.000277	0.000827	CcSEcCtD
Zalcitabine—Rash—Carmustine—melanoma	0.000276	0.000824	CcSEcCtD
Zalcitabine—Dermatitis—Carmustine—melanoma	0.000276	0.000824	CcSEcCtD
Zalcitabine—Thrombocytopenia—Docetaxel—melanoma	0.000275	0.000823	CcSEcCtD
Zalcitabine—Tachycardia—Docetaxel—melanoma	0.000274	0.00082	CcSEcCtD
Zalcitabine—Headache—Carmustine—melanoma	0.000274	0.000819	CcSEcCtD
Zalcitabine—Skin disorder—Docetaxel—melanoma	0.000273	0.000816	CcSEcCtD
Zalcitabine—Vomiting—Temozolomide—melanoma	0.000269	0.000803	CcSEcCtD
Zalcitabine—Anorexia—Docetaxel—melanoma	0.000268	0.000801	CcSEcCtD
Zalcitabine—Rash—Temozolomide—melanoma	0.000267	0.000797	CcSEcCtD
Zalcitabine—Dermatitis—Temozolomide—melanoma	0.000266	0.000796	CcSEcCtD
Zalcitabine—Headache—Temozolomide—melanoma	0.000265	0.000791	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000256	0.000765	CcSEcCtD
Zalcitabine—Insomnia—Docetaxel—melanoma	0.000254	0.00076	CcSEcCtD
Zalcitabine—Dyspnoea—Docetaxel—melanoma	0.000251	0.000749	CcSEcCtD
Zalcitabine—Somnolence—Docetaxel—melanoma	0.00025	0.000747	CcSEcCtD
Zalcitabine—Dyspepsia—Docetaxel—melanoma	0.000248	0.00074	CcSEcCtD
Zalcitabine—Decreased appetite—Docetaxel—melanoma	0.000244	0.00073	CcSEcCtD
Zalcitabine—Fatigue—Docetaxel—melanoma	0.000242	0.000724	CcSEcCtD
Zalcitabine—Pain—Docetaxel—melanoma	0.00024	0.000718	CcSEcCtD
Zalcitabine—Feeling abnormal—Docetaxel—melanoma	0.000232	0.000692	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Docetaxel—melanoma	0.00023	0.000687	CcSEcCtD
Zalcitabine—Body temperature increased—Docetaxel—melanoma	0.000222	0.000664	CcSEcCtD
Zalcitabine—Abdominal pain—Docetaxel—melanoma	0.000222	0.000664	CcSEcCtD
Zalcitabine—Hypersensitivity—Docetaxel—melanoma	0.000207	0.000619	CcSEcCtD
Zalcitabine—Asthenia—Docetaxel—melanoma	0.000202	0.000603	CcSEcCtD
Zalcitabine—Pruritus—Docetaxel—melanoma	0.000199	0.000594	CcSEcCtD
Zalcitabine—Diarrhoea—Docetaxel—melanoma	0.000192	0.000575	CcSEcCtD
Zalcitabine—Dizziness—Docetaxel—melanoma	0.000186	0.000556	CcSEcCtD
Zalcitabine—Vomiting—Docetaxel—melanoma	0.000179	0.000534	CcSEcCtD
Zalcitabine—Rash—Docetaxel—melanoma	0.000177	0.00053	CcSEcCtD
Zalcitabine—Dermatitis—Docetaxel—melanoma	0.000177	0.000529	CcSEcCtD
Zalcitabine—Headache—Docetaxel—melanoma	0.000176	0.000526	CcSEcCtD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	5.49e-05	0.00109	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—VCAN—melanoma	5.45e-05	0.00108	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	5.44e-05	0.00108	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HS3ST5—melanoma	5.17e-05	0.00103	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—melanoma	5.14e-05	0.00102	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP1B1—melanoma	4.69e-05	0.000932	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ABCB1—melanoma	4.68e-05	0.00093	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP17A1—melanoma	4.67e-05	0.000928	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1B1—melanoma	4.64e-05	0.000923	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	4.62e-05	0.000919	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP17A1—melanoma	4.6e-05	0.000914	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	4.58e-05	0.000911	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GNA11—melanoma	4.41e-05	0.000877	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ACER3—melanoma	4.39e-05	0.000873	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GNA11—melanoma	4.34e-05	0.000863	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—FASN—melanoma	4.31e-05	0.000858	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	4.3e-05	0.000856	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—FASN—melanoma	4.25e-05	0.000845	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—SLC5A5—melanoma	4.24e-05	0.000844	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	4.21e-05	0.000838	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SLC5A5—melanoma	4.18e-05	0.000831	CbGpPWpGaD
Zalcitabine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	4.11e-05	0.000818	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GNAQ—melanoma	4.1e-05	0.000815	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CD44—melanoma	4.1e-05	0.000815	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	4.04e-05	0.000803	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GNAQ—melanoma	4.04e-05	0.000803	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CD44—melanoma	4.04e-05	0.000803	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—UGT2B10—melanoma	4.02e-05	0.000799	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1B1—melanoma	3.93e-05	0.000781	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PLCB4—melanoma	3.92e-05	0.000779	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1B1—melanoma	3.87e-05	0.000769	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HS3ST5—melanoma	3.73e-05	0.000743	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC6A11—melanoma	3.68e-05	0.000732	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIP4K2A—melanoma	3.68e-05	0.000732	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.64e-05	0.000724	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.59e-05	0.000714	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTAP—melanoma	3.58e-05	0.000712	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.52e-05	0.000699	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	3.29e-05	0.000654	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	3.28e-05	0.000653	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ABCB1—melanoma	3.24e-05	0.000643	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PHGDH—melanoma	3.19e-05	0.000635	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LUM—melanoma	3.19e-05	0.000635	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ABCB1—melanoma	3.19e-05	0.000634	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HPSE—melanoma	3.13e-05	0.000622	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ACER3—melanoma	3.12e-05	0.000621	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ACER3—melanoma	3.1e-05	0.000616	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CUBN—melanoma	3.07e-05	0.000611	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.06e-05	0.000609	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.02e-05	0.000601	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PRKCA—melanoma	2.98e-05	0.000592	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SDHD—melanoma	2.97e-05	0.00059	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—BSG—melanoma	2.97e-05	0.00059	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CSPG4—melanoma	2.97e-05	0.00059	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ERCC2—melanoma	2.95e-05	0.000587	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PRKCA—melanoma	2.93e-05	0.000583	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ALB—melanoma	2.93e-05	0.000582	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ERCC2—melanoma	2.91e-05	0.000578	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPAM—melanoma	2.87e-05	0.000571	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—UGT2B10—melanoma	2.86e-05	0.000568	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—UGT2B10—melanoma	2.83e-05	0.000563	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLCB4—melanoma	2.83e-05	0.000563	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.8e-05	0.000556	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIP4K2A—melanoma	2.66e-05	0.000529	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC6A11—melanoma	2.66e-05	0.000529	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HS3ST5—melanoma	2.66e-05	0.000528	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HS3ST5—melanoma	2.63e-05	0.000523	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTAP—melanoma	2.59e-05	0.000515	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PLA2G6—melanoma	2.44e-05	0.000486	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CG—melanoma	2.33e-05	0.000464	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PHGDH—melanoma	2.31e-05	0.000459	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LUM—melanoma	2.31e-05	0.000459	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CG—melanoma	2.3e-05	0.000457	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HPSE—melanoma	2.26e-05	0.00045	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PPARG—melanoma	2.25e-05	0.000448	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CUBN—melanoma	2.22e-05	0.000442	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PPARG—melanoma	2.22e-05	0.000441	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—VCAN—melanoma	2.19e-05	0.000436	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SDHD—melanoma	2.14e-05	0.000426	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—BSG—melanoma	2.14e-05	0.000426	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CSPG4—melanoma	2.14e-05	0.000426	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.12e-05	0.000421	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPAM—melanoma	2.08e-05	0.000413	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	2.05e-05	0.000408	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CD—melanoma	2.05e-05	0.000408	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACER3—melanoma	2.04e-05	0.000406	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALB—melanoma	2.02e-05	0.000403	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CD—melanoma	2.02e-05	0.000402	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLCB4—melanoma	2.01e-05	0.0004	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLCB4—melanoma	2e-05	0.000397	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—melanoma	1.99e-05	0.000396	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	1.96e-05	0.000389	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC6A11—melanoma	1.89e-05	0.000376	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIP4K2A—melanoma	1.89e-05	0.000376	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC6A11—melanoma	1.88e-05	0.000373	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIP4K2A—melanoma	1.88e-05	0.000373	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UGT2B10—melanoma	1.87e-05	0.000371	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP17A1—melanoma	1.85e-05	0.000368	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTAP—melanoma	1.84e-05	0.000366	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTAP—melanoma	1.82e-05	0.000363	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CB—melanoma	1.79e-05	0.000355	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.78e-05	0.000355	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—melanoma	1.77e-05	0.000352	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLA2G6—melanoma	1.77e-05	0.000351	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CB—melanoma	1.76e-05	0.00035	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GNA11—melanoma	1.75e-05	0.000348	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—melanoma	1.74e-05	0.000347	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HS3ST5—melanoma	1.74e-05	0.000345	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—FASN—melanoma	1.71e-05	0.00034	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC5A5—melanoma	1.68e-05	0.000335	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LUM—melanoma	1.64e-05	0.000326	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PHGDH—melanoma	1.64e-05	0.000326	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PHGDH—melanoma	1.63e-05	0.000323	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LUM—melanoma	1.63e-05	0.000323	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GNAQ—melanoma	1.63e-05	0.000323	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CD44—melanoma	1.63e-05	0.000323	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HPSE—melanoma	1.61e-05	0.00032	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HPSE—melanoma	1.6e-05	0.000317	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—VCAN—melanoma	1.59e-05	0.000315	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CUBN—melanoma	1.58e-05	0.000314	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CUBN—melanoma	1.57e-05	0.000311	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1B1—melanoma	1.56e-05	0.00031	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTEN—melanoma	1.54e-05	0.000307	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SDHD—melanoma	1.53e-05	0.000303	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—BSG—melanoma	1.53e-05	0.000303	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CSPG4—melanoma	1.53e-05	0.000303	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTEN—melanoma	1.52e-05	0.000302	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—BSG—melanoma	1.51e-05	0.000301	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SDHD—melanoma	1.51e-05	0.000301	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CSPG4—melanoma	1.51e-05	0.000301	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPAM—melanoma	1.48e-05	0.000294	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPAM—melanoma	1.46e-05	0.000291	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP17A1—melanoma	1.34e-05	0.000266	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLCB4—melanoma	1.32e-05	0.000262	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCB1—melanoma	1.28e-05	0.000255	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GNA11—melanoma	1.26e-05	0.000251	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLA2G6—melanoma	1.26e-05	0.00025	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLA2G6—melanoma	1.25e-05	0.000248	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC6A11—melanoma	1.24e-05	0.000246	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.24e-05	0.000246	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—FASN—melanoma	1.24e-05	0.000246	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC5A5—melanoma	1.22e-05	0.000242	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTAP—melanoma	1.2e-05	0.000239	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PRKCA—melanoma	1.18e-05	0.000235	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GNAQ—melanoma	1.18e-05	0.000234	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CD44—melanoma	1.18e-05	0.000234	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ERCC2—melanoma	1.17e-05	0.000233	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—VCAN—melanoma	1.13e-05	0.000224	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1B1—melanoma	1.13e-05	0.000224	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—VCAN—melanoma	1.12e-05	0.000222	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—melanoma	1.09e-05	0.000217	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—melanoma	1.07e-05	0.000213	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PHGDH—melanoma	1.07e-05	0.000213	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LUM—melanoma	1.07e-05	0.000213	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.06e-05	0.000211	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HPSE—melanoma	1.05e-05	0.000209	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CUBN—melanoma	1.03e-05	0.000205	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.02e-05	0.000203	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SDHD—melanoma	9.97e-06	0.000198	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—BSG—melanoma	9.97e-06	0.000198	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CSPG4—melanoma	9.97e-06	0.000198	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPAM—melanoma	9.66e-06	0.000192	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP17A1—melanoma	9.52e-06	0.000189	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP17A1—melanoma	9.44e-06	0.000188	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.31e-06	0.000185	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCB1—melanoma	9.28e-06	0.000184	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—melanoma	9.25e-06	0.000184	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	9.19e-06	0.000183	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GNA11—melanoma	8.99e-06	0.000179	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARG—melanoma	8.93e-06	0.000178	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GNA11—melanoma	8.91e-06	0.000177	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—melanoma	8.9e-06	0.000177	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—FASN—melanoma	8.8e-06	0.000175	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—melanoma	8.77e-06	0.000174	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—FASN—melanoma	8.72e-06	0.000173	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC5A5—melanoma	8.65e-06	0.000172	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC5A5—melanoma	8.58e-06	0.000171	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PRKCA—melanoma	8.54e-06	0.00017	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ERCC2—melanoma	8.47e-06	0.000168	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GNAQ—melanoma	8.36e-06	0.000166	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CD44—melanoma	8.36e-06	0.000166	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GNAQ—melanoma	8.28e-06	0.000165	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CD44—melanoma	8.28e-06	0.000165	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLA2G6—melanoma	8.21e-06	0.000163	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CD—melanoma	8.13e-06	0.000162	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.11e-06	0.000161	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.04e-06	0.00016	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—melanoma	8.03e-06	0.00016	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1B1—melanoma	8.01e-06	0.000159	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1B1—melanoma	7.94e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—VCAN—melanoma	7.38e-06	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CB—melanoma	7.09e-06	0.000141	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—melanoma	7.03e-06	0.00014	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.01e-06	0.000139	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—melanoma	6.69e-06	0.000133	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCB1—melanoma	6.6e-06	0.000131	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCB1—melanoma	6.54e-06	0.00013	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARG—melanoma	6.46e-06	0.000128	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP17A1—melanoma	6.22e-06	0.000124	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—melanoma	6.13e-06	0.000122	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PRKCA—melanoma	6.07e-06	0.000121	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ERCC2—melanoma	6.02e-06	0.00012	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PRKCA—melanoma	6.02e-06	0.00012	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ERCC2—melanoma	5.97e-06	0.000119	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CD—melanoma	5.88e-06	0.000117	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GNA11—melanoma	5.88e-06	0.000117	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—melanoma	5.8e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FASN—melanoma	5.75e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC5A5—melanoma	5.66e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GNAQ—melanoma	5.46e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CD44—melanoma	5.46e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1B1—melanoma	5.24e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CB—melanoma	5.13e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—melanoma	5.08e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.95e-06	9.83e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—melanoma	4.76e-06	9.46e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—melanoma	4.72e-06	9.37e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARG—melanoma	4.59e-06	9.13e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARG—melanoma	4.55e-06	9.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—melanoma	4.43e-06	8.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—melanoma	4.32e-06	8.59e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCB1—melanoma	4.31e-06	8.58e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CD—melanoma	4.18e-06	8.31e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CD—melanoma	4.14e-06	8.24e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—melanoma	4.13e-06	8.21e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—melanoma	4.09e-06	8.14e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PRKCA—melanoma	3.97e-06	7.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ERCC2—melanoma	3.94e-06	7.83e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CB—melanoma	3.64e-06	7.25e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CB—melanoma	3.61e-06	7.18e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—melanoma	3.61e-06	7.18e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—melanoma	3.58e-06	7.12e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—melanoma	3.53e-06	7.02e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—melanoma	3.15e-06	6.26e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—melanoma	3.12e-06	6.21e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—melanoma	3.12e-06	6.21e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—melanoma	3.11e-06	6.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARG—melanoma	3e-06	5.97e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CD—melanoma	2.73e-06	5.44e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—melanoma	2.7e-06	5.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—melanoma	2.55e-06	5.07e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CB—melanoma	2.38e-06	4.74e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—melanoma	2.36e-06	4.69e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—melanoma	2.22e-06	4.42e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—melanoma	2.2e-06	4.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—melanoma	2.06e-06	4.09e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—melanoma	1.81e-06	3.61e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—melanoma	1.8e-06	3.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—melanoma	1.45e-06	2.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—melanoma	1.19e-06	2.36e-05	CbGpPWpGaD
